Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Celecoxib may be effective in preventing colorectal cancer in patients who have a
history of rectal polyps or colorectal neoplasia.
PURPOSE: Randomized phase II trial to study the effectiveness of celecoxib in preventing
colorectal cancer in patients who have a history of rectal polyps or colorectal neoplasia.